Ha habido 46 transacciones internas recientes registradas para Shuttle Pharmaceuticals Holdings, Inc. (SHPH), incluyendo 8 compras y 26 ventas. El total de compras internas fue valorado en $48K y el total de ventas internas en $50.4K.
Internos destacados con actividad reciente incluyen Liang Yuying, Pathigoda Arachchige Sachin Eranga, Liriano Angel. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.
Operaciones de Insiders — SHPH
| Fecha |
Nombre |
Cargo |
Tipo de Transacción |
Acciones |
Precio Promedio |
Valor |
Acciones en Propiedad |
| 2026-01-06 |
Liang Yuying |
Officer |
Desconocido |
- |
- |
- |
- |
| 2025-09-12 |
Pathigoda Arachchige Sachin Eranga |
Director |
Desconocido |
- |
- |
- |
- |
| 2025-09-12 |
Liriano Angel |
Director |
Desconocido |
- |
- |
- |
- |
| 2025-09-08 |
Chambers Adam V |
Director |
Desconocido |
- |
- |
- |
- |
| 2025-08-08 |
Lorber Timothy J. |
Chief Financial Officer |
Concesión de RSU |
24,854 |
- |
- |
24,854 |
| 2025-08-08 |
Scorsis George |
Director |
Concesión de RSU |
29,240 |
- |
- |
29,240 |
| 2025-08-08 |
Nabyt Oleh |
Director |
Concesión de RSU |
29,240 |
- |
- |
29,240 |
| 2025-08-08 |
Tung Joseph |
Director |
Concesión de RSU |
29,240 |
- |
- |
29,240 |
| 2025-08-08 |
Richards Steven M |
Director |
Concesión de RSU |
29,240 |
- |
- |
29,240 |
| 2025-03-11 |
Cooper Chris |
Officer |
Desconocido |
- |
- |
- |
- |
| 2025-02-28 |
Scorsis George |
Director |
Desconocido |
- |
- |
- |
184,162 |
| 2025-02-28 |
Nabyt Oleh |
Director |
Desconocido |
- |
- |
- |
184,162 |
| 2025-02-28 |
Tung Joseph |
Director |
Desconocido |
- |
- |
- |
184,162 |
| 2024-12-31 |
Schafer Joshua |
Director |
Desconocido |
- |
- |
- |
- |
| 2024-12-31 |
Richards Steven M |
Director |
Desconocido |
- |
- |
- |
- |
| 2024-12-31 |
Brown Milton |
Director |
Desconocido |
- |
- |
- |
- |
| 2024-06-13 |
Lorber Timothy J. |
Chief Financial Officer |
Disposición |
- |
- |
- |
227,635 |
| 2024-05-01 |
Jung Mira |
Chief Scientific Officer |
Devolución de RSU |
598 |
$11.28 |
$6.75K |
135,715 |
| 2024-03-08 |
Vander Hoek Michael |
Chief Financial Officer |
Concesión de RSU |
100,000 |
- |
- |
103,852 |
| 2023-12-13 |
Brown Milton |
Director |
Venta Informativa |
2,921 |
$0.46 |
$1.35K |
1,094,610 |
| 2023-12-13 |
Jacobs Bette |
Director |
Venta Informativa |
4,157 |
$0.46 |
$1.93K |
27,064 |
| 2023-08-14 |
Dritschilo Anatoly |
10 Percent Owner, Officer: CEO and Chairman |
Donación (Otorgada) |
2,100,000 |
- |
- |
1,104,407 |
| 2023-02-15 |
Brown Milton |
Director |
Concesión de RSU |
25,000 |
$1.92 |
$48K |
25,000 |
| 2022-12-29 |
Dritschilo Anatoly |
CEO and Chairman |
Venta Informativa |
8,372 |
$1.61 |
$13.44K |
1,085,200 |
| 2022-12-29 |
Rich Tyvin |
Chief Medical Officer |
Venta Informativa |
1,414 |
$1.61 |
$2.27K |
2,429 |
| 2022-12-29 |
Jung Mira |
Chief Scientific Officer |
Venta Informativa |
328 |
$1.61 |
$526.44 |
1,071,388 |
| 2022-12-29 |
Jacobs Bette |
Director |
Venta Informativa |
4,366 |
$1.61 |
$7.01K |
31,221 |
| 2022-12-29 |
Brown Milton |
Director |
Venta Informativa |
995 |
$1.61 |
$1.6K |
1,072,531 |
| 2022-12-29 |
Adkins William |
Director |
Venta Informativa |
995 |
$1.61 |
$1.6K |
184,071 |
| 2022-12-29 |
Richards Steven M |
Director |
Venta Informativa |
995 |
$1.61 |
$1.6K |
1,707 |
| 2022-12-29 |
Senanayake Chris |
Director |
Venta Informativa |
1,626 |
$1.61 |
$2.61K |
2,791 |
| 2022-12-29 |
Dritschilo Peter |
President and COO |
Venta Informativa |
3,820 |
$1.61 |
$6.13K |
6,560 |
| 2022-12-29 |
Vander Hoek Michael |
Chief Financial Officer |
Venta Informativa |
2,243 |
$1.61 |
$3.6K |
3,852 |
| 2022-10-28 |
Jacobs Bette |
Director |
Disposición |
- |
- |
- |
35,587 |
| 2022-09-02 |
Adkins William |
Director |
Otro (Compra) |
138,889 |
- |
- |
138,889 |
| 2022-08-29 |
Dritschilo Peter |
President and COO |
Disposición |
- |
- |
- |
10,380 |
| 2022-08-29 |
Dritschilo Anatoly |
10 Percent Owner, Officer: CEO and Chairman |
Disposición |
- |
- |
- |
1,070,824 |
| 2022-08-29 |
Rich Tyvin |
Chief Medical Officer |
Disposición |
- |
- |
- |
3,843 |
| 2022-08-29 |
Jung Mira |
Chief Scientific Officer |
Disposición |
- |
- |
- |
1,071,716 |
| 2022-08-29 |
Vander Hoek Michael |
Chief Financial Officer |
Disposición |
- |
- |
- |
6,095 |
| 2022-08-29 |
Adkins William |
Director |
Disposición |
- |
- |
- |
280,480 |
| 2022-08-29 |
Schafer Joshua |
Director |
Disposición |
- |
- |
- |
2,702 |
| 2022-08-29 |
Senanayake Chris |
Director |
Disposición |
- |
- |
- |
3,843 |
| 2022-08-29 |
Richards Steven M |
Director |
Disposición |
- |
- |
- |
2,702 |
| 2022-08-29 |
Dritschilo Anatoly |
10 Percent Owner, Officer: CEO and Chairman |
Disposición |
- |
- |
- |
1,093,572 |
| 2022-08-29 |
Brown Milton |
Director |
Disposición |
- |
- |
- |
1,073,526 |
■ Informativa — transacción en mercado abierto (más significativa)
■ No informativa (compra) — premio, ejercicio de opción, conversión
■ No informativa (venta) — retención fiscal, venta de adjudicación
■ Neutral — regalo, fideicomiso, vencimiento
